On 23 May, Parkway Medical Services (PMS) Hong Kong and Caritas – Hong Kong signed an MOU to redevelop Precious Blood Hospital. This partnership is set to elevate healthcare quality and service excellence for more people in the city.
The project includes renovating the current hospital, upgrading its facilities, setting up an off-site ambulatory care centre, and developing a new ambulatory clinical block.
This new block will feature a state-of-the-art medical centre for day surgeries and specialised treatments in ophthalmology, otolaryngology, and orthopaedic surgeries. Patients can look forward to a revitalised hospital that will focus on outpatient consultation, elderly healthcare, and high-volume day procedures.
PMS, a collaboration between IHH and NWS Holdings, also operates our ambulatory care centres/ clinics, diagnostic lab unit, and external collaboration projects in Hong Kong.
Leveraging its extensive hospital development expertise, this partnership with Caritas will meet the healthcare needs of patients in the neighbourhood and beyond, reinforcing our aspiration to #CareForGood.
Related Stories
Proudly the First: IHH Healthcare Singapore Achieves Full National Electronic Health Record Participation
IHH is proud to be the first private healthcare group in Singapore with all four hospitals fully contributing to the National Electronic Health Record (NEHR), reflecting our steadfast commitment to advancing continuity of care and building a more connected, patient-centred healthcare ecosystem.
Parkway Shanghai Hospital and Shanghai General Hospital Establish Strategic Partnership to Advance High-Quality Healthcare
Fortis Launches Adayu, a Hospital Dedicated to Specialised Mental Health Care
Strengthening Our Care Continuum in Shanghai
A New Chapter for Diagnostics at Mount Elizabeth Hospital
Premier Integrated Labs Transforms Operations with Cutting-edge Haematology System
On 16 October, Premier Integrated Labs redefined laboratory excellence with Malaysia’s first AI-assisted, fully automated haematology system in private practice, shaping the future of diagnostic innovation.
